BioAge Labs (BIOA) Gross Profit (2024 - 2026)

BioAge Labs has disclosed Gross Profit across 3 years of filings, most recently posting -$10.4 million for Q1 2026.

• Gross Profit for Q1 2026 came in at -$10.4 million, down 226.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$47.6 million (down 33.46% YoY), and the FY2025 annual result was -$40.5 million, down 8.95% from the prior year.
• Gross Profit came in at -$10.4 million for Q1 2026 at BioAge Labs, up from -$15.5 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of -$3.2 million in Q1 2025 to a low of -$15.5 million in Q4 2025.
• The 3-year median for Gross Profit is -$10.4 million (2026), against an average of -$9.8 million.
• Across the five-year window, Gross Profit soared 31.08% in 2025 and tumbled 226.27% in 2026, its largest moves.
• BioAge Labs' Gross Profit stood at -$13.4 million in 2024, then decreased by 16.31% to -$15.5 million in 2025, then surged by 33.27% to -$10.4 million in 2026.
• The last three Gross Profit figures came in at -$10.4 million (Q1 2026), -$15.5 million (Q4 2025), and -$10.2 million (Q3 2025), per Business Quant data.